← Back to headlines
Aclaris Therapeutics, Inc. Bullish Outlook from Stifel
Aclaris Therapeutics, Inc. is identified as a top penny stock in investors' portfolios, with Stifel expressing a bullish outlook on the company's prospects.
7 Jun, 17:59 — 7 Jun, 17:59
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Pagcor Launches P60-M Scholarship Fund for Bulacan Students
just now
Manila Water Ensures 24/7 Service Amid El Niño Through Low Nonrevenue Water
just now
Nigeria's Galaxy Backbone Attracts Banks After Data Localization Directive
just now